NASDAQ:EIGR
Delisted

Eiger Biopharmaceuticals Stock Signals

etoro logo Buy EIGR
*Your capital is at risk
$1.73
+0 (+0%)
At Close: Aug 27, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Eiger BioPharmaceuticals, Inc.

General

Signal Type Signal Value Data
Score 0.000 95 days ( 0 %
Last Price $1.73 0 %
Performance History
7 Days
$1.73 $1.73
0%
30 Days
$1.73 $1.73
0%
12 Mos
$0.86 $1.73
101.75%

5/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $1.73 - $1.73
Trend - 3 mos 0 % High Width: 0.0000000000002 %
Pred. range - 3 mos $1.73 - $1.73 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Aug 26, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.01
Signal Type Signal Value Importance Data
Trend - 12 mos 21.05 % Very High Width: 955.82 %
Pred. range - 12 mos N/A - $10.10 High -100.00 % - 485.44 %
Short MA 12 mos Sell Very High Mar 11, 2024 - 118 days
Long MA 12 mos Sell Very High Mar 28, 2024 - 105 days
Short/Long MA 12 mos Sell Very High Apr 11, 2024 - 96 days
Pivot Long Buy Low Apr 10, 2024 - 97 days
RSI Long Pivot Signal Buy Low May 03, 2024 - 80 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT EIGER BIOPHARMACEUTICALS, INC.
Eiger BioPharmaceuticals
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targe...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE